Investigational Drug Information for SAGE-718
✉ Email this page to a colleague
What is the development status for investigational drug SAGE-718?
SAGE-718 is an investigational drug.
There have been 11 clinical trials for SAGE-718.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2022.
The most common disease conditions in clinical trials are Cognitive Dysfunction, Huntington Disease, and Parkinson Disease. The leading clinical trial sponsors are Sage Therapeutics and [disabled in preview].
Summary for SAGE-718
| US Patents | 0 |
| International Patents | 50 |
| US Patent Applications | 14 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2022-12-01) |
| Vendors | 7 |
Recent Clinical Trials for SAGE-718
| Title | Sponsor | Phase |
|---|---|---|
| A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD) | Sage Therapeutics | Phase 2 |
| A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease | Sage Therapeutics | Phase 3 |
| A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive Impairment | Sage Therapeutics | Phase 2 |
Clinical Trial Summary for SAGE-718
Top disease conditions for SAGE-718
Top clinical trial sponsors for SAGE-718
US Patents for SAGE-718
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SAGE-718
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SAGE-718 | Australia | AU2014243773 | 2033-03-13 | ⤷ Try a Trial |
| SAGE-718 | Australia | AU2019201275 | 2033-03-13 | ⤷ Try a Trial |
| SAGE-718 | Australia | AU2021200205 | 2033-03-13 | ⤷ Try a Trial |
| SAGE-718 | Australia | AU2022279366 | 2033-03-13 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
